Physician profile
Rafael A Vaquer
NPI 1043244502
$766.73
in general payments reported to CMS, 2019-2025
14 companies · $65.80 in 2025
The $65.80 reported for 2025 was less than what a typical Diagnostic Radiology provider received nationally (typical 2025 total: $112).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $24.95 · 2020: $32.18 · 2021: $113 · 2022: $200 · 2023: $37.82 · 2024: $292 · 2025: $65.80.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $396.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $395.96 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Janssen Pharmaceuticals, INC | $129.80 | 2022-2025 | Erleada, Akeega |
| Abbvie INC. | $129.04 | 2024-2025 | |
| Ucb, INC. | $125.00 | 2024 | Zilbrysq |
| Genentech USA, INC. | $113.15 | 2021 | |
| Pfizer INC. | $88.74 | 2022 | |
| Ipsen Biopharmaceuticals, INC | $32.18 | 2020 | |
| E.R. Squibb & Sons, L.L.C. | $24.95 | 2019 | |
| Regeneron Healthcare Solutions, INC. | $21.67 | 2024 | Libtayo |
| Genzyme Corporation | $20.87 | 2023 | |
| Sobi, INC | $19.26 | 2025 | |
| Pbg Puerto Rico LLC | $17.12 | 2024 | |
| Eli Lilly Export S.A. Puerto Rico Branch | $16.95 | 2023 | Verzenio |
| Puma Biotechnology, INC. | $16.25 | 2025 | |
| Merck Sharp & Dohme LLC | $11.75 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Rafael Vaquer listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.